Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Clinical trial NCT00223951 · COMPLETED

Trial details

NCT number: NCT00223951
Sponsor: Vistakon Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

Start date: 2005-09-01
Primary completion: 2005-12-01
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.